Nitric oxide does not modulate the increases in blood flow, O2 consumption, or contractility during CaCl2 administration in canine hearts

Cardiovascular Research

Volumn 42, Issue 1, 1999, Pages 232-239

  Crystal, George J ^a,b   Zhou, Xiping ^a,b  

^a ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cardiac performance; Coronary hemodynamics; Dogs; Inotropic drugs; N(G) nitro L arginine methyl ester

Indexed keywords

CALCIUM CHLORIDE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW VELOCITY; CORONARY ARTERY BLOOD FLOW; DOG; DOPPLER FLOWMETRY; DRUG EFFECT; FEMALE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; INOTROPISM; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; CALCIUM CHLORIDE; CORONARY CIRCULATION; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACORPOREAL CIRCULATION; FEMALE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; OXYGEN CONSUMPTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0032920659     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00325-3     Document Type: Article

References (43)

1. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:1991;109-141.
2. Bassenge E., Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis. 30:1988;349-380.
3. Brown I.P., Thompson C.I., Belloni F.L. Role of nitric oxide in hypoxic vasodilatation in isolated guinea pig heart. Am J Physiol. 264:1993;H821-H829.
4. Smith T.P. Jr., Canty J.M. Jr. Modulation of coronary autoregulatory responses by nitric oxide. Evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res. 73:1993;232-240.
5. Yamabe H., Okumura K., Ishizaka H., Tsuchiya T., Yasue H. Role of endothelium-derived nitric oxide in myocardial reactive hyperemia. Am J Physiol. 263:1992;H8-H14.
6. Gurevicius J., Salem M.R., Metwally A.A., Silver J.M., Crystal G.J. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis. Am J Physiol. 268:1995;H39-H47.
7. Maekawa K., Saito D., Obayashi N., Uchida S., Haraoka S. Role of endothelium-derived nitric oxide and adenosine in functional myocardial hyperemia. Am J Physiol. 267:1994;H166-H173.
8. Kaneko H., Endo T., Kiuchi K., Hayakawa H. Inhibition of nitric oxide synthesis reduces coronary blood flow response but does not increase cardiac contractile response to β-adrenergic simulation in normal dogs. J Cardiovasc Pharmacol. 27:1996;247-254.
9. Parent R., Al-Obaidi M., Lavallée M. Nitric oxide formation contributes to β-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ Res. 73:1993;241-251.
10. Crystal G.J., Zhou X., Gurevicius J., Salem M.R. Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts. Anesth Analg. 87:1998;994-1001.
11. Drop L.J. Ionized calcium, the heart, and hemodynamic function. Anesth Analg. 64:1985;432-451.
12. Crystal G.J., Zhou X., Salem M.R. Is calcium a coronary vasoconstrictor in vivo? Anesthesiology. 88:1998;735-743.
13. Feigl E.O. Coronary physiology. Physiol Rev. 63:1983;1-205.
14. Xie Y.-W., Shen W., Zhao G.et al. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res. 79:1996;381-387.
15. Kelly R.A., Balligand J.-L., Smith T.W. Nitric oxide and cardiac function. Circ Res. 79:1996;363-380.
16. Crystal G.J., Gurevicius J. Nitric oxide does not modulate myocardial contractility acutely in in situ canine hearts. Am J Physiol. 270:1996;H1568-H1576.
17. Vinten-Johansen J., Johnston W.E., Crystal G.J.et al. Validation of local venous sampling within the at risk left anterior vascular bed in the canine left ventricle. Cardiovasc Res. 21:1987;646-651.
18. Ito B.R., Tate H., Kobayashi M., Schaper W. Reversibly injured, postischemic canine myocardium retains normal contractile reserve. Circ Res. 61:1987;834-846.
19. Glantz SA, Slinker BK. Primer of applied regression and analysis of variance. New York: McGraw-Hill, 1990.
20. 2 uptake during hemodilution and β-adrenergic stimulation. Am J Physiol. 265:1993;H1769-H1777.
21. Borgdorff P., Sipkema P., Westerhof N. Pump perfusion abolishes autoregulation possibly via prostaglandin release. Am J Physiol. 225:1988;H280-H287.
22. Aversano T., Maughan W.L., Hunter W.C., Kass C., Becker L.C. End-systolic measures of regional ventricular performance. Circulation. 73:1986;938-950.
23. Sadoff J.D., Scholz P.M., Weiss H.R. Endogenous basal nitric oxide production does not control myocardial oxygen consumption or function. Proc Soc Exp Biol Med. 211:1996;332-338.
24. Rosow, CE. Cardiovascular effects of narcotics. In: Covino BG, Fozzard HA, Rehder K, Strichartz G, editors. Effects of anesthesia. Bethesda, Maryland: American Physiological Society, 1985, pp. 195-203.
25. Cox R.H. Influence of pentobarbital anesthesia on cardiovascular function in trained dogs. Am J Physiol. 223:1972;651-659.
26. Gayheart P.A., Vinten-Johansen J., Johnston W.E., Hester T.O., Cordell A.R. Oxygen requirements of the dyskinetic myocardial segment. Am J Physiol. 257:1989;H1184-H1191.
27. Narishige T., Egashira K., Akatsuka Y.et al. Glibenclamide prevents coronary vasodilation induced by β-adrenoreceptor stimulation in dogs. Am J Physiol. 266:1994;H84-H92.
28. Vanhoutte P.M., Mombouli J.-V. Vascular endothelium: vasoactive mediators. Prog Cardiovasc Dis. 35:1996;229-238.
29. Crystal G.J., Rock M.H., Kim S.-J., Salem M.R. Effect of intracoronary infusions of amrinone and dobutamine on segment shortening, blood flow, and oxygen consumpton in in situ canine hearts. Anesth Analg. 79:1994;1006-1074.
30. 2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone. Br J Pharmacol. 101:1990;489-493.
31. Saeki A., Recchia F.A., Senzaki H., Kass D.A. Minimal role of nitric oxide in basal coronary flow regulation and cardiac energetics of blood-perfused isolated canine heart. J Physiol (London). 491(2):1996;455-463.
32. Kostic M.M., Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res. 70:1992;208-212.
33. Weyrich A.S., Ma X.-L., Buerke M.et al. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res. 75:1994;692-700.
34. Kojda G., Kottenberg K., Nix P.et al. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res. 78:1996;91-101.
35. de Belder A.J., Radomski M., Why H.J.et al. Nitric oxide synthase activities in human myocardium. Lancet. 341:1993;84-85.
36. de Belder A.J., Radomski M., Why H.J., Richardson P.J., Martin J.F. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvular heart disease. Br Heart J. 74:1995;426-430.
37. Haywood G.A., Tsao P.S., von der Leyen H.E.et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 93:1996;1087-1094.
38. Geng Y.-J., Hansson G.K., Holme E. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res. 71:1992;1268-1276.
39. Stadler J., Billiar T.R., Curran R.D.et al. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol. 260:1991;C910-C916.
40. Kirkebøen K.A., Naess P.A., Offstad J., Ilebekk A. Effects of regional inhibition of nitric oxide synthesis in intact porcine hearts. Am J Physiol. 266:1994;H1516-H1527.
41. Bernstein R.D., Ochoa F.Y., Xu X.et al. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res. 79:1996;840-848.
42. Kuo L., Davis M.J., Cannon M.S., Chilian W.M. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine. Circ Res. 70:1992;465-476.
43. Lefer A.M., Lefer D.J. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol. 33:1993;71-90.